CVX Chevron Corp. Stock DD Sunday, March 30, 2014 8:30:43 PM

New Post Public Reply Private Reply Replies (0) Message Board

Mar 30, 2014 at 9:30 PM

CVX Chevron Corp. $CVX Company Overview

Stock Message Board http://investorshangout.com/search?q=CVX&...mp;yt1=Go!

Last Updated: Sunday, March 30, 2014 8:30:43 PM

Chevron Corp. CVX Current Price and Quotes
Last Price 118.50
Previous Close 117.67 Open 118.13
Daily Range 118.55 - 117.70 52wk Range 127.83 - 109.27
Volume 5,875,099 Dividend 4.00
Average Vol (3m) 6,602,186 Yield 3.3755
Chevron Corp. CVX
Company Information

6001 Bollinger Canyon Road
San Ramon, CA 94583-2324

Website: http:// www.chevron.com
Phone: (925) 842-1000

Chevron Corp. CVX
Not Available

Chevron Corp. CVX
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Dec 31, 2013 10-K
CIK 0000093410
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data

SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Notes

Formerly=ChevronTexaco Corp. until 5-05
Formerly=Chevron Corp. (Old) until 10-01. Texaco, Inc. merged with Chevron Corp. (Old) prior to name change. Basis: 0.77 sh ChevronTexaco Corp. Com for each sh Texaco, Inc. Com held
Formerly=Standard Oil Co. of California to 7-84
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Chevron Corp. CVX
CVX Security Details

Share Structure

Market Value1 $217,831,770,425 a/o Mar 28, 2014
Shares Outstanding 1,909,130,328 a/o Feb 10, 2014
Float Not Available
Authorized Shares Not Available
Par Value 1.5
Shareholders

Shareholders of Record 205,000 a/o Feb 26, 2009
Corporate Actions

Ex. Date Record Date Pay Date
Dividend () Aug 15, 2002 Aug 19, 2002 Sep 10, 2002
Security Notes

Latest Block Issue=6-63 125,000 shs at $65.375 by Bache & Co. et al.
Par Changed=6-94 $3 to $1.50 Basis: shs increased by 2 for 1 split. Ex-date=6-13-94. Rec-date=5-11-94. Pay-date=6-10-94.
Short Selling Data

Short Interest (%)
Significant Failures to Deliver No
Transfer Agent(s)

BNYMellon Shareowner Services

Chevron Corp. CVX Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 220,156,000 230,590,000 244,371,000 198,198,000
Cost of Revenue 159,323,000 163,336,000 171,572,000 135,655,000
Gross Profit 60,833,000 67,254,000 72,799,000 62,543,000
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 17,573,000 17,100,000 20,373,000 22,958,000
Non-Recurring Items 1,861,000 1,728,000 1,216,000 1,147,000
Other 14,186,000 13,413,000 12,911,000 13,063,000
Operating Income 27,213,000 35,013,000 38,299,000 25,375,000
Income From Continuing Operations

Add'l Income/Expense Items 1,165,000 4,430,000 1,972,000 1,093,000
Earnings Before Interest and Tax 35,905,000 46,332,000 47,634,000 32,105,000
Interest Expense - - - 50,000
Earnings Before Tax 35,905,000 46,332,000 47,634,000 32,055,000
Income Tax 14,308,000 19,996,000 20,626,000 12,919,000
Minority Interest 174,000 157,000 113,000 112,000
Equity Earnings Unconsolidated Subsidiary 7,527,000 6,889,000 7,363,000 5,637,000
Net Income Cont. Operations 28,950,000 33,068,000 34,258,000 24,661,000
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 21,423,000 26,179,000 26,895,000 19,024,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 21,423,000 26,179,000 26,895,000 19,024,000

Chevron Corp. CVX Recent News

Mar 27, 2014 Chevron Acquires Shallow Water Acreage Offshore Myanmar
Mar 26, 2014 Chevron Demonstrates Advanced Protection of Delo 400 XLE 10W-30 at 2014 Mid-America Trucking Show
Mar 26, 2014 CEMATRIX Grants Incentive Options to Directors and Employees
Mar 20, 2014 Increased Ownership Stakes, Reaffirmed Growth Strategies, Segment Reorganization, and TRS Agreements - Analyst Notes on Schlumberger, Chevron, National Oilwell Varco, Kinder Morgan, and Seadrill
Mar 18, 2014 Chevron Increases Support for HIV Prevention in Niger Delta
Mar 13, 2014 CEMATRIX Corporation Announces Its Results for the Year Ended December 31, 2013
Mar 11, 2014 Chevron Reaffirms Strategies, Highlights Performance, Portfolio and Future Growth
Mar 10, 2014 Stock Updates on Oil & Gas Bellwethers: Chevron, Encana, Total S.A., and BP PLC
Mar 10, 2014 Ongoing Production Updates, Legal Outcomes, New Business Ventures, and Cash Tender Offers - Analyst Notes on ExxonMobil, Chevron, BP, Encana, and Murphy Oil
Mar 5, 2014 U.S. Court Declares Ecuador Judgment Against Chevron Corporation Fraudulent, Unenforceable

1
2
3
next >

CVX Chevron Corp. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CVX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CVX/quote
Stock Chart http://www.otcmarkets.com/stock/CVX/chart
Company Info http://www.otcmarkets.com/stock/CVX/company-info
Recent News http://www.otcmarkets.com/stock/CVX/news
Financials http://www.otcmarkets.com/stock/CVX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CVX/filings
Short Sales http://www.otcmarkets.com/stock/CVX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CVX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CVX/research
Summary http://finance.yahoo.com/q?s=CVX
Historical Prices http://finance.yahoo.com/q/hp?s=CVX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CVX
Basic Chart http://finance.yahoo.com/q/bc?s=CVX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CVX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CVX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CVX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CVX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CVX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CVX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CVX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CVX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CVX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CVX
Balance Sheet http://finance.yahoo.com/q/bs?s=CVX
Cash Flow http://finance.yahoo.com/q/cf?s=CVX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CVX
Market Watch http://www.marketwatch.com/investing/stock/CVX
Bloomberg http://www.bloomberg.com/quote/CVX:US
Morningstar http://quotes.morningstar.com/stock/s?t=CVX
Bussinessweek http://investing.businessweek.com/research/st...ticker=CVX
Barchart http://www.barchart.com/quotes/stocks/CVX
OTC Short Report http://otcshortreport.com/index.php?index=CVX
Investopedia http://www.investopedia.com/markets/stocks/CVX/?wa=0

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...